New appointment at Cyprotex
This article was originally published in Scrip
Executive Summary
Cyprotex, a UK-based drug discovery technology and information company, has named Ben Butterfield executive director for business development in North America. The appointment follows Cyprotex's restructuring of its US and rest of world sales activities. Mr Butterfield was previously business development manager at Toxikon, which provides preclinical safety research to medical device and pharmaceutical companies.